Company Filing History:
Years Active: 2021
Title: Craig Grant: Innovator in Pharmaceutical Chemistry
Introduction
Craig Grant is a notable inventor based in Milton Bridge, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for therapeutic use. His work is characterized by a focus on enhancing the efficacy of treatments through novel chemical formulations.
Latest Patents
Craig Grant holds a patent for a compound titled "Dimethylaminoethanol salt of a GLP-1 receptor modulator - Crystalline 2-hydroxy-N,N-dimethylethanaminium 1-(2-(5-(tert-butyl)-thiophene-2-carboxamido)-3-(4-(5-(4'-ethyl-[1,1′-bi(cyclohexan)]-3-en-4-yl)pyrimidin-2-yl)phenyl)propanoyl)azetidine-3-carboxylate salt." This patent outlines methods related to the synthesis and therapeutic use of the compound, showcasing his innovative approach to drug development.
Career Highlights
Craig is currently employed at Receptos, Inc., where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in advancing the understanding of GLP-1 receptor modulators, which play a crucial role in the treatment of various metabolic disorders.
Collaborations
Throughout his career, Craig has collaborated with esteemed colleagues such as Ephraim Vidal and Roger Bakale. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Craig Grant's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the field positively, paving the way for new therapeutic options.